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cause of implant failure. [ 2 ] To address these drawbacks surface 
biofunctionalization with bioactive motifs has extensively been 
investigated. [ 1,3 ] Thus, cell adhesive peptides and proteins from 
the extracellular matrix (ECM) have been immobilized aiming 
at increasing the material's capacity to improve the adhesion of 
osteoblast cells. [ 4 ] Alternatively, antimicrobial coatings including 
antifouling polymers, drug releasing matrices or bactericidal 
peptide sequences, have also been developed. [ 5 ] 
 As evidenced by recent research and debate in the literature, 
it is expected that the combination of distinct biological func-
tions on the surface may improve the biological performance of 
classical biomaterials. [ 6 ] However, the majority of current strate-
gies only focus on either improving cell adhesion or reducing 
bacterial adherence. Thus, the aim of the present study was to 
exploit the novel concept of multifunctionality by simultane-
ously installing cell adhesive and antimicrobial properties on 
the surface of Ti. 
 Herein, we present a new class of shell-stratifi ed amphiphilic 
polyurethane-polyurea nanoparticles (PUUa NPs,  Figure  1 A). [ 7 ] 
These innovative nanopolymeric systems display the following 
unique features: 
 (i)  NPs shell decorated with an αvβ3-selective cyclic RGD pep-
tide, which provides cell specifi city. 
 (ii)  High capacity to encapsulate hydrophobic drugs in the NPs 
oily core. 
 The RGD peptide motif, an integrin-binding sequence 
present in natural ECM proteins, such as fi bronectin and vit-
ronectin, [ 8 ] is a common cell adhesive motif used to enhance 
biointegrative effects on biomaterials. [ 9 ] In particular, the cyclic 
RGD peptide cRGDfK, designed and developed by Kessler and 
co-workers, [ 10 ] has gained increasing interest over the last years 
due to its much higher specifi city toward integrins αvβ3 and 
αvβ5, which are widely expressed by osteoblasts and bone pre-
cursors, and capacity to effectively promote osseointegrative 
events. [ 11 ] Moreover, encapsulation of an antibiotic drug in the 
PUUa NPs would tackle another recurrent problem: bacterial 
infection associated with orthopedic and dental implants sur-
gery. In this regard, the drug roxithromycin (Rx) was considered 
a promising candidate due to its potent antibacterial and anti-
infl ammatory effects. [ 12 ] Moreover, the lipophilicity of this drug 
(log P 2.9) ensured its effective encapsulation into PUUa NPs 
via hydrophobic interactions. [ 13 ] Thus, PUUa NPs represent 
an unprecedented dual approach to improve the osseointegra-
tion of implant materials: accelerated osteoblast adhesion and 
inhibition of bacterial infection (Figure  1 B). To functionalize Ti 
materials, in this work we will focus on a novel approach we 
 Metallic biomaterials such as titanium (Ti) and its alloys have 
long been used for applications in bone fi xation and regenera-
tion owing to their excellent biocompatibility and mechanical 
properties. [ 1 ] However, their use is not exempt from limitations, 
which still today may compromise the long-term performance 
of these materials. In the fi rst place, the high degree of “bioinert-
ness” displayed by such metals may, in some clinical scenarios, 
translate into poor rates of osseointegration (i.e., insuffi cient 
implant-bone interactions) and inadequate mechanical fi xa-
tion. [ 1 ] Moreover, bacterial infection and subsequent infl amma-
tion (i.e., peri-implantitis) has been described as another major 
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described as interfacial functionalization (IF), where PUUa NPs 
bearing isocyanate reactivity and Ti surfaces containing super-
fi cial amino groups react to create highly stable urea bonds in 
the metal-nanocoating interface (Figure  1 C). Signifi cantly, one 
of the major advantages of this technique relies on the effi cient 
and well established polyurethane and polyurea chemistry in the 
fi eld of industrial coatings and biomedical devices. [ 14 ] Another 
key point of this methodology with respect to other approaches 
is the wide range of molecules that can be either hydrophobi-
cally encapsulated or covalently conjugated via quantitative ure-
thane and/or urea bonds in the polymer backbone. 
 The production of PUUa NPs was based on the synthesis 
and self-assembly of a reactive amphiphilic prepolymer des-
ignated as Amphil (Figure S1, Supporting Information). This 
prepolymer bears two terminal isocyanate groups and multiple 
pendant hydrophilic and hydrophobic chains, which represent 
key structural features to mediate the stratifi cation of the PUUa 
shell in the oil–water interface. Given the fact that the hydro-
philic dangling chains of Amphil self-orient toward the water 
phase, while hydrophobic chains orient into the oily core, an 
increasing gradient of hydrophilicity is created from the hydro-
phobic core to the outer shell. This process stabilizes the struc-
ture of PUUa NPs in water and encapsulates the hydrophobic 
shell with the drug in the inner core. Hence, such emulsifi ca-
tion process yields a hydrophobically stratifi ed PUUa NP with 
high encapsulation effi ciency and capacity (see the Supporting 
Information for details). 
 Emulsifi cation in water of the reactive prepolymers was fol-
lowed by a precrosslinking step to fi x the amphiphilic structure 
of the PUUa NPs. To this end, a diamino molecule was added to 
crosslink 50% of the total amount of free isocyanate functional 
groups of the shell (Figure S3, Supporting Information). This 
methodology ensured that PUUa NPs still contained accessible 
reactive isocyanate groups for further functionalization. 
 As schematized in Figure  1 C, Ti surfaces were activated by 
oxygen plasma treatment followed by amino-silanization with 
(3-aminopropyl)triethoxysilane (APTES) to obtain an accessible 
monolayer of amino groups. Next, amino-activated Ti disks 
were immersed in reactive PUUa NPs and left to react during 
either 1 h or overnight (ON) both at 5 °C to prevent reaction of 
isocyanate groups with water. After such time, the remaining 
unreacted isocyanate groups in the NP shell were totally 
crosslinked adding the 100% of the crosslinking diamine. 
 To characterize the presence and distribution of PUUa NPs 
on Ti as well as to optimize the process of surface biofunctional-
ization, the fl uorophore Clear Blue DFSB-C0 was encapsulated 
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 Figure 1.  Installing multifunctionality on Ti. A) Schematic representation of the stratifi ed structure of PUUa NPs. B) A dual biological activity on Ti 
implants. C) Methodology to immobilize PUUa NPs on Ti by means of interfacial functionalization. D) Morphology of EDA-crosslinked PUUa NPs by 
scanning electron microscopy. E) Ti surfaces coated with fl uorescently labeled EDA-crosslinked PUUa NPs.
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into the PUUa NPs and the fl uorescence intensity on the NP-
coated surfaces quantifi ed by microscopy. Two crosslinking 
diamines of different hydrophilicity were used, L-lysine (Lys) or 
ethylenediamine (EDA). Moreover, two surface immobilization 
times were studied, 1 h and ON. As shown in Figure S4, Sup-
porting Information, statistically signifi cant higher densities of 
PUUa NPs were achieved at longer incubation times and when 
using EDA as crosslinker. Based on these data, the use of EDA 
and 1 h of incubation seemed to be optimal conditions for sur-
face biofunctionalization. 
 Fluorescence analysis also revealed a very homogenous dis-
tribution of the PUUa NPs under all conditions (Figure  1 E and 
Figure S5, Supporting Information). Moreover, scanning elec-
tron microscopy corroborated the presence of the PUUa NPs, 
which showed a well-defi ned spherical shape and suggested the 
formation of “root-like” polymeric linkages with the metallic 
surface (Figure  1 D and Figure S6, Supporting Information). 
 The stability of the coatings was also analyzed with PUUa 
NPs that contained the fl uorophore cadaverine-Oregon Green 
488 covalently anchored via urea bonds. These NPs were immo-
bilized on Ti surfaces and their stability analyzed after one and 
two weeks of incubation in phosphate-buffered saline (PBS) 
under orbital agitation. The binding of PUUa NPs onto Ti was 
proven stable under these conditions (Figure S7, Supporting 
Information). 
 As previously introduced, PUUa NPs were decorated with 
the integrin selective cRGDfK peptide to convey osseointegra-
tive properties to the surfaces. For such purpose, the free pri-
mary amine of the Lys residue of cRGDfK was the cornerstone 
of our experimental design because represented the functionali-
zation point between the polymeric shell and the peptide. Thus, 
the hydrophilic polyisocyanate linker Bayhydur 3100 (B3100) [ 15 ] 
was bounded to cRGDfK without affecting its bioactivity and 
capacity to mediate the specifi c interaction with αvβ3 integrin 
receptors [ 10b ] (Figure S1B, Supporting Information). 
 As monitored by MALDI-TOF MS and HPLC techniques 
(Figure S10 and Table S2, Supporting Information), B3100 
reacted in a quantitative manner via urea linkage with cRGDfK 
peptide in PBS. At this point, the resulting hydrophilic B3100-
cRGDfK reactive conjugate was added to the prepolymers mix-
ture, homogenized and coemulsifi ed leading to PUUa NPs 
encompassing the cRGDfK functionality in the outer shell 
(Figure S2, Supporting Information). 
 To determine the capacity of these functionalized biomate-
rials to trigger osteoblast-like cell adhesion, PUUa NPs-coated 
materials, and their controls, were incubated with sarcoma 
osteogenic (Saos-2) cells for 4 h and the number and area of 
adherent cells analyzed ( Figure  2 ). Noteworthy, the presence 
of RGD-decorated PUUa NPs (Lys RGD or EDA RGD) yielded 
an outstanding increase in both cell attachment and spreading 
compared to uncoated (Ctrol) or aminosilanized (APTES) 
Ti ( p < 0.05) (Figure  2 A,B). In particular, cells seeded on sur-
faces coated with RGD-containing NPs developed clear actin 
fi laments, and a well-defi ned cytoskeleton with some nascent 
focal adhesions (see Figure  2 C). PUUa NPs not expressing 
the RGD motif (Lys or EDA) also enhanced cell binding com-
pared to plain Ti, however these values were statistically lower 
( p < 0.05) than those achieved for RGD-decorated NPs. More-
over, PUUa NPs without the RGD motif failed to stimulate an 
adequate cell spreading and cytoskeleton (Figure  2 ), thus indi-
cating that integrin binding and activation is required to suc-
cessfully support cell adhesion. [ 16 ] Interestingly, the highest 
effi ciency in cell adhesion was observed when EDA was used 
as crosslinking diamine, which is in agreement with previous 
surface characterization data (see Figure S4, Supporting Infor-
mation). To demonstrate the long-term biological functionality 
of these coatings, cell proliferation studies were also performed 
for one and two weeks of incubation (Figure S11, Supporting 
Information). Of note, surfaces biofunctionalized with EDA 
RGD supported and promoted the growth of Saos-2 cells with 
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 Figure 2.  Adhesion of Saos-2 cells on biofunctionalized Ti surfaces after 4 h of incubation in serum free medium. A) Cell attachment (cells cm −2 ). 
B) Cell spreading (averaged cell area, µm 2 ). Cell numbers and spreading were analyzed by immunostaining and fl uorescence microscopy. Distinct let-
ters denote statistically signifi cant differences ( p < 0.05) between groups. C) Visualization of actin fi laments with phalloidin-rhodamine staining (scale 
bars: 200 µm). Visualization of vinculin on Ti surfaces functionalized with EDA-RGD was done with mouse anti-vinculin and anti-mouse Alexa 488 at 
a higher magnifi cation (images a and b, scale bar: 100 µm).
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proliferation rates statistically comparable to those obtained 
with the ECM protein fi bronectin. 
 Incorporation of antibacterial properties to the Ti surface was 
the fi nal step of our studies. In this regard, the antibiotic drug 
Rx was selected and encapsulated in our system. The encapsu-
lation effi ciency (EE) and drug loading (DL) of Rx into PUUa 
NPs was of 95% ± 1% and 9.5% ± 0.1%, respectively, as proved 
by HPLC analysis. Moreover, its in vitro drug release was moni-
tored by mixing Rx-loaded PUUa NPs with either bacterial 
growth medium or a protein and lipid-rich buffer, which aims 
to mimic physiological conditions ( Figure  3 A). 
 Interestingly, crosslinked PUUa NPs released 60%–70% 
of the encapsulated drug during the fi rst 4–6 h of incubation. 
Such initial burst release would respond to the elevated risk of 
bacterial infection described for implant materials during the 
6 h post-implantation period, [ 17 ] followed by a prolonged and 
sustained antibacterial effect. 
 Thus, as a fi nal proof of concept study, Ti surfaces were 
functionalized with PUUa NPs loaded with Rx, and bacterial 
adhesion to these surfaces investigated after 4 h of incubation. 
 Streptococcus sanguinis was chosen as model bacteria because 
this oral strain is commonly involved in peri-implantitis and 
other implant-related pathologies. [ 18 ] The susceptibility of this 
bacterial strain to Rx was demonstrated in preliminary assays 
(Figures S12 and S13, Supporting Information). As illustrated 
in Figure  3 B, PUUa NPs containing Rx were able to strongly 
suppress  S. sanguinis adhesion in a concentration-dependent 
manner. The effi cacy of our coating system after the initial 
burst release of the drug was also investigated. To this end, 
biofunctionalized samples were fi rst incubated in TH broth for 
20 h (i.e., a time point where more than the 70% of the drug is 
released, see Figure  3 A) and bacterial adhesion checked after-
ward. Noteworthy, biofunctionalized surfaces were still able to 
signifi cantly inhibit bacterial adhesion on Ti substrates (inhi-
bition rate of 76%, see Figure S14, Supporting Information). 
Therefore, PUUa NPs are not only effective in preventing ini-
tial bacterial colonization but also reducing the risk of repeti-
tive or late bacterial infection. Furthermore, the presence of Rx 
did not affect the positive effects previously observed on Saos-2 
cell adhesion (Figure S15, Supporting Information), thereby 
proving the feasibility of our strategy to confer multifunction-
ality to Ti-based materials. 
 To conclude, we have described a novel methodology to pro-
duce PUUa NPs and their immobilization on Ti surfaces. These 
systems combine outstanding cell-adhesive and antibacterial 
properties and thus represent excellent candidates to install 
multifunctionality on metallic surfaces in order to develop new 
generation biomaterials for bone regeneration. 
 Supporting Information 
 Supporting Information is available from the Wiley Online Library or 
from the author. 
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